HK1116796A1 - Aminoaryl sulphonamide derivatives as functional 5-ht6 ligands - Google Patents
Aminoaryl sulphonamide derivatives as functional 5-ht6 ligandsInfo
- Publication number
- HK1116796A1 HK1116796A1 HK08111412.9A HK08111412A HK1116796A1 HK 1116796 A1 HK1116796 A1 HK 1116796A1 HK 08111412 A HK08111412 A HK 08111412A HK 1116796 A1 HK1116796 A1 HK 1116796A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- sulphonamide derivatives
- ligands
- functional
- aminoaryl
- aminoaryl sulphonamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1127CH2005 | 2005-08-12 | ||
| PCT/IN2005/000345 WO2007020652A1 (en) | 2005-08-12 | 2005-10-26 | Aminoaryl sulphonamide derivatives as functional 5-ht6 ligands. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1116796A1 true HK1116796A1 (en) | 2009-01-02 |
Family
ID=36130030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK08111412.9A HK1116796A1 (en) | 2005-08-12 | 2008-10-15 | Aminoaryl sulphonamide derivatives as functional 5-ht6 ligands |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7998981B2 (xx) |
| EP (1) | EP1919896B1 (xx) |
| JP (1) | JP5091138B2 (xx) |
| KR (1) | KR101016972B1 (xx) |
| CN (1) | CN101258144B (xx) |
| AT (1) | ATE452885T1 (xx) |
| AU (1) | AU2005335620B2 (xx) |
| BR (1) | BRPI0520579B8 (xx) |
| CA (1) | CA2618636C (xx) |
| CY (1) | CY1110276T1 (xx) |
| DE (1) | DE602005018554D1 (xx) |
| DK (1) | DK1919896T3 (xx) |
| EA (1) | EA013875B1 (xx) |
| ES (1) | ES2337167T3 (xx) |
| HK (1) | HK1116796A1 (xx) |
| MX (1) | MX2008002018A (xx) |
| NO (1) | NO340511B1 (xx) |
| NZ (1) | NZ566495A (xx) |
| PL (1) | PL1919896T3 (xx) |
| PT (1) | PT1919896E (xx) |
| SI (1) | SI1919896T1 (xx) |
| WO (1) | WO2007020652A1 (xx) |
| ZA (1) | ZA200801276B (xx) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2670717C (en) | 2007-01-08 | 2012-01-10 | Suven Life Sciences Limited | 5-(heterocyclyl)alkyl-n-(arylsulfonyl)indole compounds and their use as 5-ht6 ligands |
| NZ581580A (en) | 2007-05-03 | 2011-03-31 | Suven Life Sciences Ltd | Aminoalkoxy aryl sulfonamide compounds and their use as 5-ht6 ligands |
| NZ585374A (en) * | 2007-10-26 | 2011-09-30 | Suven Life Sciences Ltd | Amino arylsulfonamide compounds for treating disorders related to 5-HT6 receptor functions |
| WO2010032257A1 (en) * | 2008-09-17 | 2010-03-25 | Suven Life Sciences Limited | Aryl indolyl sulfonamide compounds and their use as 5-ht6 ligands |
| EP2521714B1 (en) * | 2010-01-05 | 2015-08-12 | Suven Life Sciences Limited | Aromatic sulfone compounds useful in the treatment of central nervous disorders |
| CN102153884B (zh) * | 2011-02-16 | 2013-06-19 | 连云港清泰化工有限公司 | 一种墨水型染料及其制备方法与用途 |
| EP3083588B1 (en) | 2013-12-20 | 2020-12-09 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic compounds and their application in pharmaceuticals |
| AU2015286049B2 (en) | 2014-07-08 | 2018-03-01 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic derivatives and pharmaceutical applications thereof |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5639752A (en) * | 1991-11-25 | 1997-06-17 | Pfizer Inc | Indole derivatives |
| DZ2376A1 (fr) | 1996-12-19 | 2002-12-28 | Smithkline Beecham Plc | Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant. |
| TR200000073T2 (tr) * | 1997-07-11 | 2000-06-21 | Smithkline Beecham P.L.C. | 5-HT6 Reseptör antagonistleri olan sülfonamid türevleri ve bunların hazırlanma prosesi |
| GB9801392D0 (en) | 1998-01-22 | 1998-03-18 | Smithkline Beecham Plc | Novel compounds |
| GB9803411D0 (en) | 1998-02-18 | 1998-04-15 | Smithkline Beecham Plc | Novel compounds |
| GB9926302D0 (en) | 1999-11-05 | 2000-01-12 | Smithkline Beecham Plc | Novel compounds |
| EP1355900B1 (en) * | 2000-12-22 | 2006-05-24 | Wyeth | Heterocyclylalkylindole or -azaindole compounds as 5-hydroxytryptamine-6 ligands |
| JP4443215B2 (ja) | 2001-02-08 | 2010-03-31 | メモリ ファーマセチカル コーポレーション | ホスホジエステラーゼ４阻害剤としてのトリフルオロメチルプリン |
| MXPA04001089A (es) * | 2001-08-03 | 2004-05-20 | Upjohn Co | 5-arilsulfonil indoles que tienen afinidad por el receptor de 5-ht. |
| US20050255529A1 (en) | 2002-02-01 | 2005-11-17 | Stefan Golz | Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor |
| WO2003066056A1 (en) | 2002-02-05 | 2003-08-14 | Glaxo Group Limited | Method of promoting neuronal growth |
| JP4467307B2 (ja) * | 2002-02-22 | 2010-05-26 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | ５−ｈｔ受容体アンタゴニストとしてのピリジルスルホン誘導体 |
| PL374401A1 (en) | 2002-06-05 | 2005-10-17 | F.Hoffmann-La Roche Ag | 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders |
| CN1309384C (zh) * | 2002-10-18 | 2007-04-11 | 弗·哈夫曼-拉罗切有限公司 | 具有5－ht6受体亲和性的4－哌嗪基苯磺酰基吲哚 |
| JP4559230B2 (ja) | 2002-11-28 | 2010-10-06 | スベン ライフ サイエンシズ リミティド | セロトニン受容体に対する親和性を有する新規ｎ−アリールスルホニル−３−置換されたインドール、その調製方法、それを含有する医薬組成物 |
| PT1567492E (pt) | 2002-11-28 | 2013-07-22 | Suven Life Sciences Ltd | N-arilsulfonil-3-aminoalcoxi-indóis |
| WO2004048331A1 (en) | 2002-11-28 | 2004-06-10 | Suven Life Sciences Limited | N-arylalkyl-3-aminoalkoxyindoles and their use as 5-ht ligands |
| BRPI0316895C1 (pt) | 2002-12-18 | 2021-05-25 | Suven Life Sciences Ltd | composto, processo para a preparação do composto, composição farmacêutica e uso do composto |
| AU2004271741A1 (en) * | 2003-09-12 | 2005-03-24 | Laboratoires Serono Sa | Sulfonamide derivatives for the treatment of diabetes |
-
2005
- 2005-10-26 NZ NZ566495A patent/NZ566495A/en not_active IP Right Cessation
- 2005-10-26 PT PT05813800T patent/PT1919896E/pt unknown
- 2005-10-26 AU AU2005335620A patent/AU2005335620B2/en not_active Ceased
- 2005-10-26 ES ES05813800T patent/ES2337167T3/es active Active
- 2005-10-26 EA EA200800573A patent/EA013875B1/ru not_active IP Right Cessation
- 2005-10-26 CN CN2005800515505A patent/CN101258144B/zh not_active Expired - Fee Related
- 2005-10-26 PL PL05813800T patent/PL1919896T3/pl unknown
- 2005-10-26 MX MX2008002018A patent/MX2008002018A/es active IP Right Grant
- 2005-10-26 CA CA2618636A patent/CA2618636C/en not_active Expired - Fee Related
- 2005-10-26 AT AT05813800T patent/ATE452885T1/de active
- 2005-10-26 WO PCT/IN2005/000345 patent/WO2007020652A1/en active Application Filing
- 2005-10-26 SI SI200530928T patent/SI1919896T1/sl unknown
- 2005-10-26 JP JP2008525723A patent/JP5091138B2/ja not_active Expired - Fee Related
- 2005-10-26 DK DK05813800.9T patent/DK1919896T3/da active
- 2005-10-26 KR KR1020087005968A patent/KR101016972B1/ko active IP Right Grant
- 2005-10-26 US US11/990,383 patent/US7998981B2/en not_active Expired - Fee Related
- 2005-10-26 DE DE602005018554T patent/DE602005018554D1/de active Active
- 2005-10-26 EP EP05813800A patent/EP1919896B1/en active Active
- 2005-10-26 BR BRPI0520579A patent/BRPI0520579B8/pt not_active IP Right Cessation
-
2008
- 2008-02-06 ZA ZA200801276A patent/ZA200801276B/xx unknown
- 2008-02-08 NO NO20080705A patent/NO340511B1/no not_active IP Right Cessation
- 2008-10-15 HK HK08111412.9A patent/HK1116796A1/xx not_active IP Right Cessation
-
2010
- 2010-02-04 CY CY20101100110T patent/CY1110276T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ566495A (en) | 2010-06-25 |
| AU2005335620B2 (en) | 2009-12-10 |
| ZA200801276B (en) | 2009-02-25 |
| JP2009504633A (ja) | 2009-02-05 |
| AU2005335620A1 (en) | 2007-02-22 |
| JP5091138B2 (ja) | 2012-12-05 |
| US7998981B2 (en) | 2011-08-16 |
| MX2008002018A (es) | 2008-03-27 |
| BRPI0520579B8 (pt) | 2021-05-25 |
| NO20080705L (no) | 2008-05-06 |
| BRPI0520579B1 (pt) | 2019-08-06 |
| CY1110276T1 (el) | 2015-01-14 |
| EA200800573A1 (ru) | 2008-08-29 |
| CA2618636C (en) | 2011-01-18 |
| SI1919896T1 (sl) | 2010-04-30 |
| PL1919896T3 (pl) | 2010-05-31 |
| KR20080039984A (ko) | 2008-05-07 |
| KR101016972B1 (ko) | 2011-02-25 |
| EP1919896A1 (en) | 2008-05-14 |
| CA2618636A1 (en) | 2007-02-22 |
| ES2337167T3 (es) | 2010-04-21 |
| WO2007020652A1 (en) | 2007-02-22 |
| NO340511B1 (no) | 2017-05-02 |
| BRPI0520579A2 (pt) | 2009-11-10 |
| DE602005018554D1 (de) | 2010-02-04 |
| ATE452885T1 (de) | 2010-01-15 |
| DK1919896T3 (da) | 2010-04-19 |
| EP1919896B1 (en) | 2009-12-23 |
| EA013875B1 (ru) | 2010-08-30 |
| US20100168168A1 (en) | 2010-07-01 |
| CN101258144B (zh) | 2012-05-30 |
| CN101258144A (zh) | 2008-09-03 |
| PT1919896E (pt) | 2010-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1116796A1 (en) | Aminoaryl sulphonamide derivatives as functional 5-ht6 ligands | |
| SI1888541T1 (sl) | Benzo(d)izoksazol-3-il-aminske spojine in njihova uporaba kot ligandi vaniloidnega receptorja | |
| MX2009003316A (es) | Derivados de pirazina-2-carboxamida como moduladores receptores de cb2. | |
| EA200900048A1 (ru) | Новые карбонилированные (аза)циклогексаны в качестве лигандов d3 рецептора дофамина | |
| TW200740814A (en) | Compounds | |
| EA200970967A1 (ru) | Оксадиазол замещенные производные индазола для применения в качестве агонистов сфингозин 1-фосфата (sip) | |
| PT1877364E (pt) | Derivados fenilacetileno com afinidade para o receptor mglur5 | |
| EA200700365A1 (ru) | Производные индол-2-карбоксамидина как антагонисты nmda рецептора | |
| MX2008002805A (es) | Derivados de carboxamida como antagonistas del receptor muscarinico. | |
| WO2007142905A3 (en) | 1-sulfonylindazolylamine and -amide derivatives as 5-hydroxytryptamine-6 ligands | |
| WO2007108936A3 (en) | N-substituted-azacyclylamines as histamine-3 antagonists | |
| DE602006018713D1 (de) | Als agonisten für den nikotinischen acetylcholinrezeptor geeignete azabicycloalkanderivate | |
| MX2010002760A (es) | Derivados de isoquinolinilo e isoindolinilo como antagonistas de la histamina-3. | |
| WO2008059339A3 (en) | Isoquinoline derivatives as vanilloid receptor modulators | |
| EA200870606A1 (ru) | Серосодержащие производные пиразола в качестве избирательных антагонистов рецептора каннабиноидов св | |
| UA94053C2 (ru) | Замещенные производные 3-сульфонилиндазола в качестве лигандов гидрокситриптамина-6 | |
| MX2008002158A (es) | Derivados de azinil-3-sulfonilindazol como ligandos de 5-hidroxitriptamina-6. | |
| DK2155674T3 (da) | Aminoalkoxy-aryl-sulfonamidforbindelser og anvendelse heraf som 5-HT6-ligander | |
| HK1120424A1 (en) | Carbazole derivatives as functional 5-ht6 ligands | |
| MX2008012824A (es) | Derivados de sulfonil-3-heterociclilindazol como ligandos de 5-hidroxitriptamina-6. | |
| UA89846C2 (ru) | Производные карбоксамида как антагонисты мускариновых рецепторов |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20201027 |